Also, similarly to candesartan, pioglitazone suppresses transforming growth factor-β1 (TGF-β1) and tumor necrosis factor-α (TNF-α) expression in atrial tissue, molecules that are inflammatory mediators related to fibrosis-mediated AF incidence [29]. The gene discussed is TGFB1; the disease is atrial fibrillation.